Home LiteratureArticle Details
PMID: 2871553 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.

Masui T, Wakefield LM, Lechner JF, LaVeck MA, Sporn MB, Harris CC

Abstract

Type beta transforming growth factor (TGF-beta) was shown to be the serum factor responsible for inducing normal human bronchial epithelial (NHBE) cells to undergo squamous differentiation. NHBE cells were shown to have high-affinity receptors for TGF-beta. TGF-beta induced the following markers of terminal squamous differentiation in NHBE cells: (i) increase in Ca ionophore-induced formation of crosslinked envelopes; (ii) increase in extracellular activity of plasminogen activator; (iii) irreversible inhibition of DNA synthesis; (iv) decrease in clonal growth rate; and (v) increase in cell surface area. The IgG fraction of anti-TGF-beta antiserum prevented both the inhibition of DNA synthesis and the induction of differentiation by either TGF-beta or whole blood-derived serum. Therefore, TGF-beta is the primary differentiation-inducing factor in serum for NHBE cells. In contrast, TGF-beta did not inhibit DNA synthesis of human lung carcinoma cells even though the cells possess comparable numbers of TGF-beta receptors with similar affinities for the factor. Epinephrine antagonized the TGF-beta-induced inhibition of DNA synthesis and squamous differentiation of NHBE cells. Although epinephrine increased the cyclic AMP levels in NHBE cells, TGF-beta did not alter the intracellular level in NHBE cells in either the presence or absence of epinephrine. Therefore, epinephrine and TGF-beta appear to affect different intracellular pathways that control growth and differentiation processes of NHBE cells.

MeSH Terms
Bronchi/cytology,physiology Cell Cycle/drug effects Cell Differentiation Cell Line Cells, Cultured Cyclic AMP/metabolism Epinephrine/pharmacology Epithelial Cells Growth Substances/physiology Humans Lung Neoplasms/pathology Peptides/physiology Receptors, Cell Surface/physiology Receptors, Transforming Growth Factor beta Transforming Growth Factors
Chemicals
Growth Substances Peptides Receptors, Cell Surface Receptors, Transforming Growth Factor beta Transforming Growth Factors Cyclic AMP Epinephrine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Masui T
Wakefield L M
Lechner J F
LaVeck M A
Sporn M B
Harris C C
References (52)
52 references, click to expand
  1. Differential properties among clones of simian virus 40-transformed human epithelial cells.
    Carcinogenesis. 1980 Aug;1(8):635-45 PMID: 11272117
  2. Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.
    Proc Natl Acad Sci U S A. 1984 Nov;81(21):6757-61 PMID: 6208555
  3. Control of growth of mammalian cells in cell culture.
    Nature. 1975 Dec 11;258(5535):487-90 PMID: 1105198
  4. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.
    J Cyclic Nucleotide Res. 1975;1(4):207-18 PMID: 177461
  5. Differentiation of the epidermal keratinocyte in cell culture: formation of the cornified envelope.
    Cell. 1976 Dec;9(4 Pt 1):511-21 PMID: 1009573
  6. Terminal differentiation of cultured human epidermal cells.
    Cell. 1977 Jun;11(2):405-16 PMID: 302145
  7. Use of staphylococcal protein A as an immunological reagent.
    J Immunol Methods. 1978;20:241-53 PMID: 349081
  8. Growth factors from murine sarcoma virus-transformed cells.
    Proc Natl Acad Sci U S A. 1978 Aug;75(8):4001-5 PMID: 211512
  9. Cyclic AMP in relation to proliferation of the epidermal cell: a new view.
    Cell. 1978 Nov;15(3):801-11 PMID: 83196
  10. Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factor.
    J Cell Physiol. 1978 Dec;97(3 Pt 1):371-80 PMID: 215597
  11. Differential effects of cAMP and cGMP on in vitro epidermal cell growth.
    Exp Cell Res. 1979 Apr;120(1):201-10 PMID: 220065
  12. Application of the principles of enzyme kinetics to clonal growth rate assays: an approach for delineating interactions among growth promoting agents.
    J Cell Physiol. 1979 Sep;100(3):519-29 PMID: 385606
  13. Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions.
    Cell. 1979 Nov;18(3):681-94 PMID: 42494
  14. Clonal growth of human keratinocytes with small amounts of dialyzed serum.
    In Vitro. 1980 Jun;16(6):526-40 PMID: 6156122
  15. Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes.
    Cell. 1980 Nov;22(2 Pt 2):629-32 PMID: 6160916
  16. Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis.
    Nature. 1981 Sep 3;293(5827):72-4 PMID: 6791032
  17. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.
    Proc Natl Acad Sci U S A. 1981 Sep;78(9):5339-43 PMID: 6975480
  18. Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF.
    Nature. 1982 Feb 4;295(5848):417-9 PMID: 6276769
  19. Coupling of growth arrest and differentiation at a distinct state in the G1 phase of the cell cycle: GD.
    Proc Natl Acad Sci U S A. 1982 Feb;79(3):845-9 PMID: 6174983
  20. Mouse embryos contain polypeptide growth factor(s) capable of inducing a reversible neoplastic phenotype in nontransformed cells in culture.
    J Cell Physiol. 1982 Feb;110(2):169-74 PMID: 6279682
  21. Serum contains a platelet-derived transforming growth factor.
    Proc Natl Acad Sci U S A. 1982 Sep;79(17):5312-6 PMID: 6957865
  22. Neoplastic transformation and defective control of cell proliferation and differentiation.
    Cancer Res. 1982 Dec;42(12):5139-46 PMID: 6291749
  23. Clonal growth of normal adult human bronchial epithelial cells in a serum-free medium.
    In Vitro. 1982 Jul;18(7):633-42 PMID: 7141447
  24. Interactions between the receptors for platelet-derived growth factor and epidermal growth factor.
    J Cell Biol. 1983 Mar;96(3):679-83 PMID: 6300138
  25. Plasminogen activator in differentiating mouse keratinocytes.
    J Invest Dermatol. 1983 Apr;80(4):217-22 PMID: 6682129
  26. Transforming growth factors from neoplastic and nonneoplastic tissues.
    Fed Proc. 1983 Jun;42(9):2621-6 PMID: 6303865
  27. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.
    J Biol Chem. 1983 Jun 10;258(11):7155-60 PMID: 6602130
  28. Purification and initial characterization of a type beta transforming growth factor from human placenta.
    Proc Natl Acad Sci U S A. 1983 Jun;80(12):3676-80 PMID: 6602340
  29. Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.
    Proc Natl Acad Sci U S A. 1983 Sep;80(18):5627-30 PMID: 6310584
  30. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.
    Proc Natl Acad Sci U S A. 1983 Oct;80(20):6264-8 PMID: 6604914
  31. Differential control by platelet factors of squamous differentiation in normal and malignant human bronchial epithelial cells.
    Cancer Res. 1983 Dec;43(12 Pt 1):5915-21 PMID: 6640540
  32. Purification and properties of a type beta transforming growth factor from bovine kidney.
    Biochemistry. 1983 Dec 6;22(25):5692-8 PMID: 6607069
  33. Transforming growth factor-beta controls receptor levels for epidermal growth factor in NRK fibroblasts.
    Cell. 1984 Jan;36(1):35-41 PMID: 6319010
  34. Rat transforming growth factor type 1: structure and relation to epidermal growth factor.
    Science. 1984 Mar 9;223(4640):1079-82 PMID: 6320373
  35. G proteins and dual control of adenylate cyclase.
    Cell. 1984 Mar;36(3):577-9 PMID: 6321035
  36. Acute effects of 12-O-tetradecanoylphorbol-13-acetate, teleocidin B, or 2,3,7,8-tetrachlorodibenzo-p-dioxin on cultured normal human bronchial epithelial cells.
    Carcinogenesis. 1984 Feb;5(2):209-15 PMID: 6421503
  37. Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.
    Science. 1984 Nov 9;226(4675):705-7 PMID: 6093254
  38. Homologies between signal transducing G proteins and ras gene products.
    Science. 1984 Nov 16;226(4676):860-2 PMID: 6436980
  39. Functional homology of mammalian and yeast RAS genes.
    Cell. 1985 Jan;40(1):19-26 PMID: 2981628
  40. In yeast, RAS proteins are controlling elements of adenylate cyclase.
    Cell. 1985 Jan;40(1):27-36 PMID: 2981630
  41. Type beta transforming growth factor: a bifunctional regulator of cellular growth.
    Proc Natl Acad Sci U S A. 1985 Jan;82(1):119-23 PMID: 3871521
  42. Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity.
    Proc Natl Acad Sci U S A. 1985 Jan;82(2):376-80 PMID: 2982154
  43. Transformation of human bronchial epithelial cells transfected by Harvey ras oncogene.
    Science. 1985 Mar 8;227(4691):1174-9 PMID: 3975607
  44. An initiator of carcinogenesis selectively and stably inhibits stem cell differentiation: a concept that initiation of carcinogenesis involves multiple phases.
    Proc Natl Acad Sci U S A. 1985 May;82(9):2995-9 PMID: 3857629
  45. Relationship of ornithine decarboxylase activity and cAMP metabolism to proliferation of normal human bronchial epithelial cells.
    J Cell Physiol. 1985 Aug;124(2):207-12 PMID: 2995414
  46. Induction of squamous differentiation of normal human bronchial epithelial cells by small amounts of serum.
    Differentiation. 1984;25(3):229-37 PMID: 6698333
  47. Cellular transformation by coordinated action of three peptide growth factors from human platelets.
    Nature. 1984 Jun 28-Jul 4;309(5971):804-6 PMID: 6330562
  48. Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts.
    J Biol Chem. 1984 Sep 10;259(17):10995-1000 PMID: 6088525
  49. Comparative biochemical properties of normal and activated human ras p21 protein.
    Nature. 1984 Aug 23-29;310(5979):644-9 PMID: 6147754
  50. Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies.
    J Cell Physiol. 1984 Oct;121(1):31-44 PMID: 6207187
  51. Differential effects of 12-O-tetradecanoylphorbol-13-acetate on cultured normal and neoplastic human bronchial epithelial cells.
    Cancer Res. 1984 Nov;44(11):5124-6 PMID: 6488172
  52. Differentiation of normal and malignant cells.
    Fed Proc. 1970 May-Jun;29(3):1248-54 PMID: 5462712
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1986-04-00
Pages
2438-42
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC323313
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com